New MotherToBaby Study Targets Pregnancy Data Gap for Newer Eczema TreatmentThe FDA has determined that human pregnancy data for Ebglyss® remain insufficient. By enrolling U.S. and Canadian participants, this study will help generate the evidence needed to inform future treatment decisions.